NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
FAQ: Amerigo Scientific's New 3D Bioprinting Portfolio for Biomedical Research
TL;DR
Amerigo Scientific's 3D bioprinter portfolio gives researchers a competitive edge by accelerating drug discovery and enabling more predictive tissue models for therapeutic development.
Amerigo Scientific's 3D bioprinters use precise extrusion control and multi-material printing to reproducibly construct complex tissue models with high cell viability.
This technology advances regenerative medicine by enabling patient-specific tissue grafts and scaffolds, potentially improving wound healing and organ repair outcomes for patients.
Scientists can now create intricate 3D tissue constructs using Amerigo Scientific's bioprinters that replicate the complex microenvironment of human tissues for research.
Found this article helpful?
Share it with your network and spread the knowledge!
Amerigo Scientific has launched a comprehensive portfolio of 3D bioprinters and biomaterials, including extrusion-based 3D printers and high-performance bioinks, to accelerate biomedical research.
This integrated ecosystem lowers the barrier to entry for complex 3D biology work and accelerates the path from basic research to therapeutic applications by providing end-to-end solutions for creating functional 3D tissues.
The portfolio includes 3D printers based on extrusion technology that feature multi-material printing capabilities and advanced extrusion control systems.
Key features include multi-material printing for creating heterogeneous tissue constructs, precise pneumatic and screw-driven extrusion systems for high cell viability, and the ability to handle various bioinks and printing techniques.
Amerigo Scientific offers an extensive selection of biomaterials and bioinks that are thoroughly tested by academia and the tissue engineering industry to yield optimal biological results.
The products will accelerate research in drug discovery and development, regenerative medicine, and cancer research by enabling the creation of more predictive 3D tissue models and patient-specific tissue constructs.
The full portfolio of 3D bioprinters and biomaterials is available for order immediately as of the November 20, 2025 announcement.
Researchers can visit www.amerigoscientific.com to get more information, request a quote, or speak with a product specialist.
Amerigo Scientific's mission is to equip researchers with innovative tools needed for groundbreaking discoveries by providing reliable, easy-to-use 3D bioprinting solutions that enable precise and reproducible tissue construction.
The combination of advanced biological printing hardware and professional materials allows researchers to replicate the complex microenvironment of human tissues and create 3D models with greater physiological relevance for more accurate research outcomes.
Curated from 24-7 Press Release
